Tech Company Financing Transactions

Mission Therapeutics Funding Round

Mission Therapeutics, operating out of Cambridge, secured $31.7 million in investment from IP Group, Pfizer Venture Investments and Roche Venture Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

The Glenn Berge Building Babraham Research Campus Babraham
Cambridge, CB22 3FH
UK

Phone

+44 (0)1223 607 340

Website

www.missiontherapeutics.com

Email Address

[email protected]

Overview

Mission Therapeutics is a world leader in developing novel therapeutics which combat serious diseases including Parkinson's Disease by enhancing mitophagy -- the vital quality control process cells use to ensure dysfunctional mitochondria are removed.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Steve Jackson

        

Chief Executive Officer

Anker Lundemose

        

Chief Financial Officer

David Luther

        

Chief Medical Officer

Suhail Nurbhai

        

Chief Scientific Officer

Paul Thompson

        

Browse more venture capital transactions:

Prev: 3/14/2024: Redcoat AI venture capital transaction
Next: 3/15/2024: Clique venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary